| Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis LY Ye, W Chen, XL Bai, XY Xu, Q Zhang, XF Xia, X Sun, GG Li, QD Hu, ... Cancer research 76 (4), 818-830, 2016 | 257 | 2016 |
| Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas Q Zhang, Y Lou, J Yang, J Wang, J Feng, Y Zhao, L Wang, X Huang, Q Fu, ... Gut 68 (11), 2019 | 250 | 2019 |
| Hypoxia‐inducible factor‐1α/interleukin‐1β signaling enhances hepatoma epithelial–mesenchymal transition through macrophages in a hypoxic‐inflammatory microenvironment J Zhang, Q Zhang, Y Lou, Q Fu, Q Chen, T Wei, J Yang, J Tang, J Wang, ... Hepatology 67 (5), 1872-1889, 2018 | 244 | 2018 |
| Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer Q Fu, Q Zhang, Y Lou, J Yang, G Nie, Q Chen, Y Chen, J Zhang, J Wang, ... Oncogene 37 (47), 6105-6118, 2018 | 148 | 2018 |
| Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer Q Zhang, Y Lou, J Zhang, Q Fu, T Wei, X Sun, Q Chen, J Yang, X Bai, ... Molecular cancer 16, 1-14, 2017 | 114 | 2017 |
| Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling XL Bai, Q Zhang, LY Ye, F Liang, X Sun, Y Chen, QD Hu, QH Fu, W Su, ... Oncogene 34 (31), 4089-4097, 2015 | 92 | 2015 |
| Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy X Bao, H Zhang, W Wu, S Cheng, X Dai, X Zhu, Q Fu, Z Tong, L Liu, ... Journal for immunotherapy of cancer 8 (2), 2020 | 70 | 2020 |
| Anti–PD-1/PD-L1 blockade immunotherapy employed in treating hepatitis B virus infection–related advanced hepatocellular carcinoma: a literature review B Li, C Yan, J Zhu, X Chen, Q Fu, H Zhang, Z Tong, L Liu, Y Zheng, ... Frontiers in Immunology 11, 1037, 2020 | 69 | 2020 |
| Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis M Ye, Q Zhang, Y Chen, Q Fu, X Li, X Bai, T Liang Hpb 22 (6), 821-832, 2020 | 60 | 2020 |
| Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma L Liu, R Zhang, J Deng, X Dai, X Zhu, Q Fu, H Zhang, Z Tong, P Zhao, ... Cancer Immunology, Immunotherapy 71 (1), 121-136, 2022 | 57 | 2022 |
| Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages Q Chen, J Wang, Q Zhang, J Zhang, Y Lou, J Yang, Y Chen, T Wei, ... British journal of cancer 121 (9), 786-795, 2019 | 57 | 2019 |
| The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway Y Chen, X Bai, Q Zhang, L Wen, W Su, Q Fu, X Sun, Y Lou, J Yang, ... Cancer Letters 380 (1), 98-105, 2016 | 53 | 2016 |
| Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis QH Fu, Q Zhang, XL Bai, QD Hu, W Su, YW Chen, RG Su, TB Liang Journal of cancer research and clinical oncology 140, 1429-1440, 2014 | 48 | 2014 |
| Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas XL Bai, Q Zhang, LY Ye, QD Hu, QH Fu, X Zhi, W Su, RG Su, T Ma, ... Molecular cancer therapeutics 13 (8), 2062-2072, 2014 | 47 | 2014 |
| Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma X Dai, Y Guo, Y Hu, X Bao, X Zhu, Q Fu, H Zhang, Z Tong, L Liu, Y Zheng, ... Theranostics 11 (7), 3489, 2021 | 46 | 2021 |
| A redox-sensitive, oligopeptide-guided, self-assembling, and efficiency-enhanced (ROSE) system for functional delivery of microRNA therapeutics for treatment of hepatocellular LTTG Hu Q, Wang K, Sun X, Li Y Biomaterials, 192-200, 2016 | 44 | 2016 |
| The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer X Li, D Huang, Q Zhang, C Guo, Q Fu, X Zhang, TY Tang, W Su, YW Chen, ... Pancreatology 20 (1), 95-100, 2020 | 31 | 2020 |
| Meta-analysis of invagination and duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: An update X Sun, Q Zhang, JY Zhang, Y Lou, QH Fu, XL Zhang, TB Liang, XL Bai International Journal of Surgery 36, 240-247, 2016 | 31 | 2016 |
| Sister Mary Joseph’s nodule as a first sign of pancreatic cancer XL Bai, Q Zhang, W Masood, N Masood, Y Tang, CH Cao, QH Fu, ... World Journal of Gastroenterology: WJG 18 (45), 6686, 2012 | 28 | 2012 |
| Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis PP Jin, SY Shao, WT Wu, XY Zhao, BF Huang, QH Fu, RS Que, QD Hu Japanese Journal of Clinical Oncology 48 (12), 1058-1069, 2018 | 24 | 2018 |
Tingbo Liang 梁廷波The First Affiliated Hospital, Zhejiang University School of MedicineBestätigte E-Mail-Adresse bei zju.edu.cn
